Polychlorinated biphenyls (PCBs) comprise a group of 209 former industrial chemicals that are classified as toxic, bioaccumulative, and environmentally persistent ([@r38]). Many PCBs, particularly the lower-chlorinated PCB congeners (LC-PCBs), possess semivolatile properties and are detected globally in air, with the highest concentrations being found in industrialized urban areas ([@r5]; [@r17]; [@r49]). In contrast to the higher-chlorinated congeners, LC-PCBs are more susceptible to metabolic conversion, but their fate and toxicities within the human body remain relatively poorly understood ([@r37]). Considering the abundance of LC-PCBs, and the resulting public health concerns, the identification of their toxicologically relevant metabolites and their molecular targets is essential for risk assessment purposes. To date, research has been primarily focused on the toxicological effects of parent PCBs and their hydroxylated metabolites (OH-PCBs).

Certain OH-PCBs have been identified as excellent substrates for cytosolic sulfotransferases (SULTs), a family of enzymes that catalyze the formation of sulfate conjugates ([@r13]; [@r25]; [@r47]; [@r48]). [@r12] recently reported that the formation of sulfate conjugates is a major metabolic pathway for PCB 3 in rats, thereby providing evidence for the formation of PCB sulfates *in vivo*. Despite these indications of the potential for the formation of PCB sulfates *in vivo*, their fates and toxicities have not yet been characterized.

The thyroid gland is a target of PCB toxicity. Chronic exposure to commercial PCB mixtures increases the mass of the thyroid gland and the number of thyroid neoplasms ([@r28]). Both of these changes may be linked to a PCB-driven reduction in serum levels of thyroid hormones ([@r18]), a commonly measured result of PCB exposure ([@r32]). Parent PCBs and OH-PCBs are known thyroid disruptors that induce multiple effects on the thyroid homeostatic system in a congener-dependent manner ([@r3]; [@r6]; [@r31]). Epidemiological studies have revealed a correlation between prenatal PCB exposure and behavioral effects, decreased cognitive function, and mental retardation in infants, and these effects may be caused by PCB-induced alterations of the thyroid status in the fetal brain ([@r4]; [@r11]; [@r39]). A significant contributing mechanism in PCB-induced hypothyroxinemia is the displacement of [l]{.smallcaps}-thyroxine (T~4~) from its binding sites on the thyroid hormone transport protein transthyretin (TTR) ([@r15]; [@r19]; [@r45], [@r46]). TTR is the main transporter of T~4~ in the cerebrospinal fluid and is, in addition to serum albumin and thyroxine-binding globulin, one of three thyroid hormone carriers in human plasma ([@r22]; [@r34]). Certain OH-PCBs were previously identified as ligands for TTR that were capable of competing with T~4~ for its two binding sites ([@r21]; [@r35]; [@r36]). These sites exhibit negative cooperativity and, as a result, only one molecule of T~4~ is bound to TTR under physiological conditions ([@r14]). Due to TTR's suggested role as a mediator for the transport of thyroid hormones across the blood--brain barrier and the placenta, structurally specific binding of PCB metabolites to T~4~ binding sites on TTR is assumed to interfere with the delivery of thyroid hormones to target tissues in the brain and the fetus and may also facilitate the transport of bound ligands to these compartments ([@r7], [@r6]; [@r30]; [@r40]).

Structural similarities between PCB sulfates and T~4~ led us to hypothesize that PCB sulfates represent a class of high-affinity ligands for human TTR. To test this hypothesis, we characterized the binding of five LC-PCB sulfates to TTR and compared their equilibrium dissociation constants (*K*~d~ values) to those determined for their hydroxylated precursors and for T~4~. In addition, we conducted docking simulations to determine the potential molecular interactions of these sulfates within the T~4~ binding site of TTR. Additional studies addressed the reversibility of the interaction of PCB sulfates with TTR and the likelihood that human sulfotransferase 1A1 (hSULT1A1) can catalyze the formation of these PCB sulfates.

The parent PCBs of all metabolites used in this study have been detected in Chicago, Illinois, air ([@r17]). Of particular interest is the sulfate ester derived from PCB 11. Its parent PCB congener is a major component of PCBs present in Chicago and Cleveland, Ohio, air, yet it was never contained in any of the commercial PCB mixtures ([@r17]; [@r33]). Current research suggests that PCB 11 is a by-product of paint and pigment production, thus representing a continuing source for PCB exposure ([@r16]).

Methods
=======

*Chemicals*. Hydroxylated PCBs (4´-chloro-biphenyl-2-ol, 4´-chloro-biphenyl-3-ol, 4´-chloro-biphenyl-4-ol, 3,3´-dichloro-biphenyl-4-ol, and 3´,4´-dichloro-biphenyl-4-ol) and the ammonium salts of 2´-sulfooxy-4-chloro-biphenyl, 3´-sulfooxy-4-chloro-biphenyl, 4-chloro-4´-sulfooxy-biphenyl, and 3,4-dichloro-4´-sulfooxy-biphenyl were synthesized and characterized as previously described ([@r23]; [@r24]). The ammonium salt of 3,3´-dichloro-4´-sulfooxy-biphenyl was synthesized and characterized as described in Supplemental Material, p. 2 (<http://dx.doi.org/10.1289/ehp.1206198>). 8-Anilinonaphthalene-1-sulfonic acid (ANS), [l]{.smallcaps}-thyroxine sodium salt pentahydrate (i.e., T~4~), adenosine-3´-phosphate-5´-phosphosulfate lithium salt hydrate (PAPS), adenosine-3´,5´-diphosphate sodium salt (PAP), sodium phosphate monobasic, and TTR purified from human plasma (\> 95%) were purchased from Sigma-Aldrich (St. Louis, MO). TTR was used without further purification and its purity was routinely confirmed by SDS-PAGE. The protein concentration was determined by the Bradford assay. PAPS was purified to ≥ 98% purity according to a procedure published by [@r41]. Cytosolic extract of *E. coli* expressing recombinant hSULT1A1 (cytosolic protein concentration of 10 mg/mL) (Xenotech, Lenexa, KS) was used without further purification. Acetonitrile was purchased from Fisher Scientific (Hampton, NH). Sodium chloride, potassium phosphate monobasic, and ammonium chloride were obtained from Research Products International (Mt. Prospect, IL).

*ANS displacement assay*. ANS displacement studies have frequently been used to determine dissociation constants for potential ligands of TTR ([@r8]; [@r10]; [@r43]). We determined *K*~d~ values for PCB metabolites and T~4~ utilizing a modified version of a previously published procedure ([@r10]). A solution containing 0.5 µM TTR and 5 µM ANS (total volume 1,000 µL) in phosphate buffer \[50 mM sodium phosphate, 100 mM NaCl (sodium chloride); pH 7.4\] was titrated with small aliquots of PCB metabolites or T~4~ (structures shown in [Figure 1](#f1){ref-type="fig"}) using a glass syringe (Hamilton, Reno, NV). The displacement of ANS was monitored by measuring the decrease in fluorescence intensity at 470 nm upon excitation of the molecule at 410 nm in a Spectramax M5 fluorimeter (Molecular Devices, Sunnyvale, CA) \[for details, see Supplemental Material, Figure S1 (http://dx.doi.org/10.1289/ehp.1206198)\]. Three fluorescence measurements were averaged per determination, and at least three separate determinations were made at each ligand concentration. The protocol was optimized for ligand concentrations of ≤ 2,000 nM, and assays were conducted at 25°C (± 0.2°C) in quartz cuvettes with a 1-cm path length. The fluorescence was corrected for dilution (≤ 4.6% of the total volume) and was found to be unaffected by the solvent of the ligands \[0.5 mM NaOH (sodium hydroxide)\] and the duration of the assay (see Supplemental Material, Figure S2). The total change in pH was ≤ 0.01 pH units. The concentration of ANS in phosphate buffer was determined spectrophotometrically at 350 nm using a molar extinction coefficient of 6.3 × 10^3^/cm/M ([@r20]). Binding data were evaluated by fitting the means of each determination to both a one-site plus nonspecific binding equation \[*y* = (*B*~max1~ × *x*)/(*K*~d1~ + *x*) + **Ns**\] and a two-site binding equation \[*y* = (*B*~max1~ × *x*)/(*K*~d1~ + *x*) + (*B*~max2~ × *x*)/(*K*~d2~ + *x*)\]. In these equations, *K*~d1~ is the dissociation constant for the TTR-ligand complex and *K*~d2~ is the dissociation constant for the TTR complex with two bound ligands, *B*~max1~ and *B*~max2~ are the relative changes in fluorescence required to saturate the respective binding sites and **Ns** is a constant representing low-affinity interactions. In this case, the **Ns** term includes both the low-affinity second T~4~ binding site in TTR and any other low-affinity interaction with the protein. The variables *x* and *y* represent ligand concentrations and changes in fluorescence (Δ fluorescence), respectively. Best fits for *K*~d1~ were obtained by fitting data in the 0--100 nM range to the one-site plus nonspecific binding equation. In order to determine *K*~d2~ values, all available data points were fit to the two-site binding equation.

![Chemical structures of PCB sulfates, OH-PCBs, and T~4~. PCB sulfates used in this study were synthesized as ammonium salts.](ehp.1206198.g001){#f1}

*HPLC analysis of PCB sulfates*. TTR (0.5 µM) and PCB sulfate (5 µM) were incubated in phosphate buffer (50 mM sodium phosphate, 100 mM NaCl; pH 7.4) at 25°C (± 0.5°C) for 120 min. After 0, 60, and 120 min, 20 µL samples were analyzed for PCB sulfates by chromatography on a C18 HPLC column with a linear acetonitrile gradient (15--95%) in triethylammonium acetate (1% vol/vol; pH 7.5). Detailed HPLC conditions and representative chromatograms are provided in Supplemental Material, Figure S3 (<http://dx.doi.org/10.1289/ehp.1206198>).

*Molecular docking simulations*. All docking simulations were performed using SYBYL X software (Tripos, St. Louis, MO). From the Protein Data Bank (PDB; <http://www.wwpdb.org/>), we selected the crystal structure complex of TTR with bound 2,´6´-difluorobiphenyl-4-carboxylic acid (PDB no. 2F7I) to constitute the receptor model for human TTR. The receptor structure was prepared according to protocols provided by Tripos. Briefly, protein chain termini were set into their charged states, and hydrogen atoms were added before staged minimizations were performed with the Powell method, using the MMFF94s force field. Ligands present in the crystal structure were extracted from the receptor and used to define the active site (protomol). Default settings were used for protomol generation. Ligands (2´PCB 3 sulfate, 3´PCB 3 sulfate, 4´PCB 3 sulfate, 4´PCB 11 sulfate, 4´PCB 12 sulfate) were modeled in ChemBioDraw 12.0 (PerkinElmer, Waltham, MA) and imported into a SYBYL X database. All ligands were energy-minimized using the Tripos force field and docked into prepared receptor structures using the Surflex-Dock module in Geom mode. Twenty different binding poses were generated per molecule and ranked according to their binding energies. Images were created using the PyMOL Molecular Graphics System (version 1.5.0.4; Schrödinger LLC, New York, NY).

*Sulfotransferase assay*. The assays for sulfation of OH-PCBs catalyzed by hSULT1A1 were conducted according to a previously published procedure ([@r25]). Assay mixtures containing 0, 10, 20, or 30 µM of the potential substrate were preincubated at 37°C in the presence of 200 µM PAPS and 7.5 mM 2-mercaptoethanol in 250 mM potassium phosphate at pH 7.0. After adding 1 µL of cytosolic extract of *E. coli* expressing hSULT1A1 (10 µg cytosolic protein), the reaction mixture (total volume 30 µL) was incubated for 10 min before the reaction was terminated by the addition of 30 µL methanol. Samples (20 µL) were subsequently analyzed by HPLC to determine the amount of PAP formed in the reaction ([@r42]).

Results
=======

*Binding of T~4~ and PCB metabolites to TTR*. We determined *K*~d~ values for T~4~ of 4.7 ± 1.1 nM and 234 ± 11 nM at the high- and low-affinity binding sites on TTR, respectively \[[Figure 2A](#f2){ref-type="fig"}; see also Supplemental Material, Figure S4A (http://dx.doi.org/10.1289/ehp.1206198)\]. These values are in agreement with previously published data for T~4~ binding to TTR ([@r10]; [@r43]; [@r45], [@r46]). After validating the assay conditions, we determined *K*~d~ values for five PCB sulfates and their hydroxylated precursors ([Figure 2](#f2){ref-type="fig"}; see also Supplemental Material, Figure S5). All five PCB sulfates were found to be ligands for the high-affinity binding site, with *K*~d1~ values ranging from 4.8 nM to 16.8 nM. 2´PCB 3 sulfate, 3´PCB 3 sulfate, and 4´PCB 11 sulfate exhibited significantly higher affinities (i.e., lower *K*~d1~ values) than their respective OH-PCBs ([Table 1](#t1){ref-type="table"}). Although the *K*~d1~ for 4´PCB 3 sulfate (14.5 nM) was lower than the one for 4´OH-PCB 3 (19.3 nM), the difference was not significant. The lowest *K*~d1~ was obtained for 4´PCB 11 sulfate (4.8 nM) ([Figure 2C](#f2){ref-type="fig"} and [Table 1](#t1){ref-type="table"}). 4´OH-PCB 12 had the highest-affinity binding in this study, and it exhibited a significantly lower dissociation constant (*K*~d1~ = 2.7 nM) than its sulfate (16.8 nM) and T~4~ (4.7 nM). *K*~d~ values determined for the low-affinity binding site revealed a clustered pattern for mono- and dichlorinated PCB metabolites. Although dichlorinated PCB metabolites bound with *K*~d2~ values ranged from 624 to 825 nM ([Table 1](#t1){ref-type="table"}; see also Supplemental Material, Figure S4A), the chosen concentration range of ≤ 2,000 nM was insufficient to facilitate quantitative displacement of ANS from the second binding site by PCB 3 metabolites (see Supplemental Material, Figure S4B). All lower chlorinated PCB metabolites exhibited significantly higher *K*~d2~ values than T~4~.

![Binding of T~4~, 4´OH-PCB11, and 4´PCB 11 sulfate to the high-affinity site on TTR. Data for the binding of T~4~ (*A*), 4OH-PCB 11 (*B*), and 4´PCB 11 sulfate (*C*) were determined by ANS displacement using ligand concentrations between 0 and 100 nM. Data were fit to a one-site plus nonspecific binding equation; data points represent means of at least three experiments (Table 1); error bars indicate SDs.](ehp.1206198.g002){#f2}

###### 

*K*~d~ values determined for PCB metabolites and T~4~.

  Compound                                                                                                                                                                                                                                                                                                                                                  *n*   *K*~d1~ (nM)   *p*-Value^*a*^   *p*-Value^*b*^   *K*~d2~ (nM)     *p*-Value^*c*^
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----- -------------- ---------------- ---------------- ---------------- ----------------
  T~4~                                                                                                                                                                                                                                                                                                                                                      4     4.7 ± 1.1      --               --               234 ± 11         --
  2´OH-PCB 3                                                                                                                                                                                                                                                                                                                                                4     19.8 ± 6.0     --               0.004            ^*d*^            --
  2´PCB 3 sulfate                                                                                                                                                                                                                                                                                                                                           3     5.4 ± 1.2      0.015            0.458            ^*d*^            --
  3´OH-PCB 3                                                                                                                                                                                                                                                                                                                                                4     14.8 ± 2.0     --               \< 0.001         ^*d*^            --
  3´PCB 3 sulfate                                                                                                                                                                                                                                                                                                                                           3     8.2 ± 1.0      0.007            0.008            ^*d*^            --
  4´OH-PCB 3                                                                                                                                                                                                                                                                                                                                                3     19.3 ± 3.8     --               \< 0.001         ^*d*^            --
  4´PCB 3 sulfate                                                                                                                                                                                                                                                                                                                                           4     14.5 ± 4.0     0.206            0.005            ^*d*^            --
  4´OH-PCB 11                                                                                                                                                                                                                                                                                                                                               8     13.9 ± 1.8     --               \< 0.001         624 ± 207^*e*^   0.004
  4´PCB 11 sulfate                                                                                                                                                                                                                                                                                                                                          3     4.8 ± 0.7      \< 0.001         0.897            624 ± 63         \< 0.001
  4´OH-PCB 12                                                                                                                                                                                                                                                                                                                                               3     2.7 ± 0.5      --               0.035            825 ± 47         \< 0.001
  4´PCB 12 sulfate                                                                                                                                                                                                                                                                                                                                          4     16.8 ± 5.8     0.014            0.008            742 ± 58         \< 0.001
  ^***a***^PCB sulfates compared with their OH-PCBs (*K*~d1~).^***b***^PCB sulfates compared with T~4~ (*K*~d1~).^***c***^PCB sulfates compared with T~4~ (*K*~d2~).^***d***^*K*~d~ values could not be determined for the second site because of low-affinity binding.^***e***^Best fit was obtained using a one-site plus nonspecific binding equation.                                                                           

*Stability of PCB sulfates in the assay.* In order to determine the stability of PCB sulfates under the conditions of the assay for binding to TTR, we developed an HPLC procedure for the separation and quantification of PCB sulfates and their respective OH-PCBs. Using a linear 15--95% acetonitrile gradient, we were able to separate all five matching pairs of PCB sulfates from their OH-PCB precursors \[see Supplemental Material, Figure S3 (http://dx.doi.org/10.1289/ehp.1206198)\]. Using this procedure, we quantitatively recovered 5 µM samples of 2´PCB 3 sulfate, 3´PCB 3 sulfate, 4´PCB 3 sulfate, 4´PCB 11 sulfate, and 4´PCB 12 after incubation with 0.5 µM TTR under ANS assay conditions (see Supplemental Material, Figure S6). Moreover, quantitative recovery of the PCB sulfates by HPLC indicated that the binding to TTR is reversible under the conditions of HPLC analysis.

*Selection of a receptor structure for docking simulations*. TTR is a 55-kDa homotetrameric protein consisting of a dimer of dimers in a twofold symmetrical arrangement. The interface between the two dimers forms a channel that contains two T~4~ binding sites ([@r2]; [@r50]). Each T~4~ binding site is lined with mostly hydrophobic residues that form two symmetrical sets of three halogen-binding pockets, P1--P3 and P1´--P3´ ([@r2]). P1 and P1´ are located on the outside of the channel and comprise side chains of residues Met13, Lys15, Thr106, and Ala108. On the outermost part of this pocket, Lys15 and Glu54 form a charged region that provides the possibility for polar interactions between protein and ligands. The side chains of Lys15, Leu17, Ala109, and Leu110 form P2 and P2´. P3 and P3´, the innermost binding pockets, are formed by side chains of Ala108, Leu110, Ser117, and Thr119. The crystal structure of T~4~ bound to TTR (PDB no. 2ROX) indicates a binding orientation in which the alanyl moiety of T~4~ facilitates hydrogen bonding interactions with Lys15 and Glu54, and the phenol is oriented towards Ser117 and Thr119 ([@r50]). Iodine substituents in the 3 and 5 position of thyroxine are positioned in P2 and P3, respectively. We initially selected three TTR crystal structure complexes with different bound ligands (PDB no. 2ROX, 2G9K, and 2F7I) from the PDB to constitute the receptor model for TTR. Following extraction of the ligands and subsequent docking of the extracted ligands into the generated protomol, the closest match was obtained for the complex of 2´,6´-difluorobiphenyl-4-carboxylic acid and TTR (PDB no. 2F7I). The docked ligand revealed similar positioning and molecular interactions within the binding site as compared with the crystal structure ([Figure 3A](#f3){ref-type="fig"}). In particular, the carboxylate of 2´,6´-difluorobiphenyl-4-carboxylic acid engages in hydrogen bonding interactions with Lys15. The 2´ and 6´ fluorine substituents are located in P3 and P3´. Because of the lack of fluorines on the unsubstituted ring, it shows some flexibility and is twisted approximately 90° in the docked structure as compared with the crystal structure.

![Molecular docking of PCB sulfates into the T~4~ binding site on TTR. (*A*) Comparison between the original crystal structure (PDB no. 2F7I, blue) and docked 2´,6´-difluorobiphenyl-4-carboxylic acid/TTR (red) complex. (*B--F*) Views of the TTR binding site are shown after docking with 4´PCB 11 sulfate (*B*), 4´PCB 12 sulfate (*C*), 2´PCB 3 sulfate (*D*), 3´PCB 3 sulfate (*E*), and 4´PCB 3 sulfate (*F*).](ehp.1206198.g003){#f3}

*Docking simulations for PCB sulfates*. Using PDB no. 2F7I as the receptor model, we were able to dock all five PCB sulfates into the T~4~ binding site ([Figure 3B--F](#f3){ref-type="fig"}). To be consistent in the interpretation of our docking results, only the lowest-energy binding conformation is indicated per PCB sulfate. The lowest-energy binding conformations indicated an orientation that enables hydrogen bonding interactions between the sulfate groups and Lys15. The only exception was 2´PCB 3 sulfate, where hydrogen bonding with Lys15 residues was sterically unfavorable. Instead, the sulfate moiety of 2´PCB 3 sulfate formed a hydrogen bond with Leu110, resulting in a reverse orientation of this metabolite. The binding modes of 4´PCB 11 sulfate and 4´PCB 12 sulfate, the only two compounds with chlorines in the *meta* position were similar to those previously determined for T~4~. Whereas the sulfate group facilitates hydrogen bonding with Lys15, the *meta*-positioned chlorines appeared to be inserted, analogously to the iodines in T~4~, into P2 and P3. It should be noted that some of the higher-energy binding poses obtained for PCB sulfates exhibited an antiparallel orientation with the sulfate group pointing towards the central Ser117.

*OH-PCBs as substrates for hSULT1A1*. Because formation of PCB sulfates requires their metabolic formation from OH-PCBs, we determined the rate of sulfation of OH-PCBs by recombinant hSULT1A1. The five OH-PCBs that were tested in this study were substrates for the enzyme and exhibited a concentration-dependent increase in the rate of sulfation ([Figure 4](#f4){ref-type="fig"}). The highest specific activities were determined for the *ortho*-hydroxylated 2´OH-PCB 3 and for the *meta*-hydroxylated 3´OH-PCB 3. The *para*-hydroxylated 4´OH-PCB 3, 4´OH-PCB 11, and 4´OH-PCB 12 exhibited slightly lower specific activities. Thus, the hSULT1A1, a major human cytosolic sulfotransferase, catalyzes the sulfation of these OH-PCBs.

![OH-PCBs are substrates for human SULT1A1. The sulfation of 2´OH-PCB 3, 3´OH-PCB 3, 4´OH-PCB 3, 4´OH-PCB 11, and 4´OH-PCB 12 is catalyzed by a cytosolic extract of *E. coli* expressing recombinant hSULT1A1. \**p* \< 0.05, and \*\**p* \< 0.001 compared with 0 µM OH-PCB](ehp.1206198.g004){#f4}

Discussion
==========

Several recent studies have demonstrated the potential of OH-PCB metabolites to serve as substrates for sulfotransferases *in vitro* and *in vivo* ([@r12]; [@r13]; [@r25]). Importantly, using a rat model [@r12] observed that serum concentrations of PCB 3 sulfates greatly exceeded those of their respective OH-PCBs, thereby suggesting that in contrast to the higher-chlorinated PCBs and OH-PCBs that tend to be retained in blood and adipose tissue, LC-PCBs undergo relatively rapid oxidation and conjugation upon absorption. Considering the abundance of LC-PCBs in indoor and outdoor air samples ([@r17]; [@r27]), these discoveries raise concern about both the fate and potential toxicities of PCB sulfates.

In the present study, we have demonstrated the ability of five LC-PCB sulfates to bind with high affinity to the most physiologically relevant binding site for T~4~ on human TTR. Using a fluorescence displacement assay, we determined that *K*~d~ values for the high-affinity binding site ranged from 4.8 nM to 16.8 nM and were thus comparable to T~4~ (4.7 nM). Importantly, four of the five PCB sulfates (2´PCB 3 sulfate, 3´PCB 3 sulfate, 4´PCB 3 sulfate, and 4´PCB 11 sulfate) interacted with higher affinities than their corresponding OH-PCBs. Although OH-PCBs have been previously shown to be high-affinity ligands for TTR that are capable of competing with T~4~ ([@r15]; [@r21]; [@r36]), our results now establish the potential for binding of PCB sulfates to TTR. Some of the higher-chlorinated OH-PCBs are several times more potent ligands for TTR than T~4~ ([@r9]; [@r36]; [@r45], [@r46]). It is possible that some higher-chlorinated PCB sulfates may exhibit even higher affinities for TTR than the lower-chlorinated ones used here, although testing of this hypothesis and evaluating the role of sulfation in the metabolism of such higher-chlorinated PCBs will await further studies. Besides PCB mono-sulfates, which constituted the largest group of metabolites in serum of PCB 3--exposed rats, the recent metabolism study on PCB 3 also reported detectable levels of mercapturic acid conjugates and sulfate esters derived from dihydroxylated metabolites, albeit at lower levels ([@r12]). The binding characteristics of such metabolites remain to be characterized in subsequent studies because they might contribute to the displacement of T~4~ from binding sites on TTR. Although glucuronide conjugates were not major metabolic products for PCB 3 ([@r12]), we also cannot rule out the possibility of biological effects of these conjugates.

Supporting evidence for high-affinity binding of PCB sulfates to TTR was provided by molecular docking simulations. With the exception of 2´PCB 3 sulfate, the sulfate moiety facilitated hydrogen bonding interactions with Lys15 residues, thereby dictating the binding orientation of the PCB sulfate. The *ortho*-sulfate group in 2´PCB 3 sulfate appears to sterically prevent this interaction. Instead, the orientation of the molecule is reversed, which enables hydrogen bonding of the sulfate with Leu110. Among the PCB 3 sulfates, 2´PCB 3 sulfate bound significantly better to the high-affinity binding site than 3´PCB 3 sulfate or 4´PCB 3 sulfate ([Table 1](#t1){ref-type="table"}), and this may be due to the alternate binding orientation within the T~4~ binding site. In addition, the observed increased affinity of 4´PCB 11 sulfate as compared with 4´PCB 12 sulfate can be explained by the presence of a second *meta*-chlorine that provides the opportunity for additional anchorage within binding pockets P3 or P3´. This finding is consistent with previous reports indicating that *meta*- and *para*-chlorination increases affinities of OH-PCBs to TTR ([@r9]; [@r29]; [@r36]).

Similar to T~4~, *K*~d~ values determined for the second binding site on TTR were found to be at least two orders of magnitude higher than those determined for the high-affinity binding site ([@r10]; [@r43]). *K*~d2~ values determined for all PCB metabolites were significantly higher than for T~4~. These weaker interactions with the second binding site are consistent with the negative cooperativity between these sites that is observed with T~4~ ([@r14]). T~4~, although structurally similar to PCB metabolites, is a larger molecule with a higher degree of halogenation than the PCB metabolites used in this study. These differences may account for a sterically more favorable binding to the second site. However, under physiological conditions, concentrations of T~4~ are too low to allow binding to the low-affinity binding site ([@r26]). Consequently, the displacement of T~4~ by PCB metabolites primarily affects the high-affinity binding site *in vivo*, whereas both sites may have relevance in the (inter-tissue) transport and retention of xenobiotics.

Whereas in cerebrospinal fluid TTR is the only TH transporter, in human serum the displacement of T~4~ from binding sites on two additional T~4~ transport proteins, albumin and thyroxine binding globulin, may be a contributing factor in the saturation of T~4~ binding sites and should be addressed in further studies. However, previous research has emphasized the displacement of T~4~ from TTR as a key contributing mechanism in organohalogen-induced hypothyroxinemia ([@r15]; [@r19]). TTR has additional relevance owing to its function as a mediator for the transport of thyroid hormones across the placenta and the blood--brain barrier, and it has been suggested that the binding of PCB metabolites to TTR may facilitate their transport to the cerebrospinal fluid and to the fetus ([@r7], [@r6]; [@r40]; [@r44]). Recently, it was reported that TTR has the potential for translocation across the placenta into the fetal circulation and represents a potential shuttle system for thyroid hormones and for exogenous compounds ([@r30]). Considering their ability to bind with high affinity to TTR, the PCB sulfates used in this study possess the basic requirements for such inter-tissue transport. Moreover, the observations that their binding affinities do not exceed those determined for T~4~, and that their interactions are noncovalent, points towards their ability to dissociate from TTR upon delivery to potential target tissues. Although higher-chlorinated PCB sulfates remain to be examined for their binding to TTR, previous reports suggest that the higher-chlorinated OH-PCBs may be less able to dissociate and may be retained bound to TTR in the circulation ([@r1]; [@r7]). Likewise, future research will be required to further assess levels of human exposure to PCB sulfates as well as the *in vivo* effects of PCB sulfates on T~4~ concentrations in susceptible tissues and/or transport of PCB sulfates into those tissues.

Conclusions
===========

We have identified five LC-PCB sulfates as high-affinity ligands for human TTR. Notably, their binding affinities were similar to those determined for their respective OH-PCB precursors and for T~4~. The binding interactions between all five PCB sulfates and TTR were found to be noncovalent. We used docking simulations to calculate their lowest-energy binding conformations within the thyroxine binding sites of human TTR, thereby providing corroborating evidence for their high-affinity binding, and insight into potential binding orientations. Moreover, the corresponding OH-PCBs were found to be substrates for hSULT1A1, a major human cytosolic sulfotransferase. Thus, these results indicate, for the first time, a potential toxicological relevance of PCB sulfates in the disruption of thyroid hormone homeostasis in tissues dependent upon TTR-mediated transport.
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